Schedule 13D ownership disclosure

Mirati Therapeutics Inc

Security class unavailable · CUSIP: 60468T105

Event date: 2017-01-27

Legacy cover-page extraction is best effort and may not include every reporting person.

Filing-level shares
Unavailable
Percent of class
5.3000%

Amounts are as disclosed in this filing. Schedule type alone does not establish investment intent.

Source: SEC EDGAR filing

Filing metadata

Accession number
0001193125-17-023732
Form type
SC 13D/A
Filer
Boxer Capital, LLC
CIK
CIK 1465837
Filed
Jan 30, 2017
Reporting period
Jan 27, 2017
Description
Schedule 13D beneficial ownership

Explore SEC Filings Hub